(19) |
 |
|
(11) |
EP 3 988 138 A8 |
(12) |
CORRECTED EUROPEAN PATENT APPLICATION |
|
Note: Bibliography reflects the latest situation |
(15) |
Correction information: |
|
Corrected version no 1 (W1 A1) |
(48) |
Corrigendum issued on: |
|
07.09.2022 Bulletin 2022/36 |
(43) |
Date of publication: |
|
27.04.2022 Bulletin 2022/17 |
(22) |
Date of filing: 22.10.2020 |
|
(51) |
International Patent Classification (IPC):
|
|
(84) |
Designated Contracting States: |
|
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL
NO PL PT RO RS SE SI SK SM TR |
|
Designated Extension States: |
|
BA ME |
|
Designated Validation States: |
|
KH MA MD TN |
(71) |
Applicant: Georg-August-Universität Göttingen Stiftung
Öffentlichen Rechts, Universitätsmedizin |
|
37075 Göttingen (DE) |
|
(72) |
Inventors: |
|
- ZIMMERMANN, Wolfram-Hubertus
37073 Göttingen (DE)
- TIBURCY, Malte
37083 Göttingen (DE)
- MEYER, Tim
37083 Göttingen (DE)
|
(74) |
Representative: Wichmann, Hendrik |
|
Wuesthoff & Wuesthoff
Patentanwälte PartG mbB
Schweigerstraße 2 81541 München 81541 München (DE) |
|
|
|
(54) |
MULTILAYER ENGINEERED HEART MUSCLE |
(57) The application describes a method for manufacturing a multilayer engineered heart
muscle. Specifically, the method relates to (i) providing a liquid reconstitution
mixture in a mould and (ii) culturing said mixture. The method is characterized by
a sequential addition of one or more further liquid reconstitution mixtures in order
to obtain a multilayer engineered heart muscle. Said muscle ideally has the form of
a patch, a pouch, or a cylinder. Furthermore, the application relates to a multilayer
engineered heart muscle comprising collagen, cardiac myocytes and non-myocytes originating
from at least 2 layers. Said multilayer engineered heart muscle forms the basis for
several
in vitro and
in vivo applications such as the production of a multilayer engineered heart muscle for use
in a patient, for example for use in heart repair.